ZDHHC6 and breast carcinoma: Breast cancer MCF-7 cells treated with 30 μM ART or ART-yne (24 h) identified zDHHC6 as a co-interacting partner [196]; as a result, the palmitoylation status of zDHHC6 substrates was altered including H-Ras [196].